Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
1.
Acta Laboratorium Animalis Scientia Sinica ; (6): 57-64, 2018.
Article in Chinese | WPRIM | ID: wpr-703188

ABSTRACT

Objective Cysteinyl leukotrienes are potent inflammatory mediators. Their actions are mediated by specific receptors,the CysLT receptors(CysLT1R and CysLT2R),which have been cloned and characterized. In this stud-y,we investigated the protective effects of the CysLTR antagonist Pranlukast and HAMI 3379 on global cerebral ischemia/reperfusion(CI/R)injury in gerbils and its underlying mechanisms. Methods The gerbil model of CI/R was established by bilateral common carotid artery occlusion for 10 min followed by 24 h reperfusion. Then the animals were equally ran-domized into four groups: sham, model, Pranlukast(0.1 mg/kg)and HAMI 3379(0.1 mg/kg)groups. The later two groups were treated with intraperitoneal injection of Pranlukast and HAMI 3379,respectively,once daily for 4 days before carotid artery occlusion,while the former two groups with saline only,all at 10 mL/kg. After 24 h reperfusion,neurologi-cal deficit scores were observed and the behavioral dysfunction was assessed. The neuron morphology of cerebral cortex and CA1 subregion of hippocampus were observed in brain sections stained with cresyl violet. The expression of autophagy-relat-ed proteins beclin-1 and LC3 in the homogenate of cerebral cortex and hippocampus were determined using western blotting analysis. The ultrastructure of autophagosomes in the CA1 subregion of hippocampus was observed by electron microscopy. Results Compared with the model group, Pranlukast and HAMI 3379 attenuated neurological deficits, improved the be-havioral dysfunction,inhibited the neuron injury and loss, decreased the expression of autophagy-related protein beclin-1 and LC3 and the number of autophagosomes. Conclusions cysteinyl Leukotriene receptor antagonist Pranlukast and HAMI 3379 can alleviate global cerebral ischemia/reperfusion injury in gerbils. The protective effects of Pranlukast and HAMI 3379 appear to be associated with the inhibition of autophagy.

2.
Chinese Journal of Lung Cancer ; (12): 219-222, 2007.
Article in Chinese | WPRIM | ID: wpr-339299

ABSTRACT

<p><b>BACKGROUND</b>Chemotherapy is very important in treatment of advanced non-small cell lung cancer (NSCLC), and the third-generation cisplatin-based chemotherapy regimens have been the standard treatment for advanced NSCLC. The aim of this study is to compare the efficacy and toxicity among four different chemotherapeutic regimens combined with radiotherapy in patients with stage III/IV NSCLC.</p><p><b>METHODS</b>A total of 527 patients with stage III/IV NSCLC were enrolled, among whom there were 243 patients received cisplatin/vinorelbine (NP group), 163 patients for cisplatin/paclitaxel (TP group), 65 patients for cisplatin/gemcitabine (GP group) and 56 patients for cisplatin/docetaxel (DP group). The efficacy, side effects, median time to progression (TTP), median survival time (MST), 1- and 2-year survival rate were compared.</p><p><b>RESULTS</b>The response rate was 46.9% in the NP arm, 44.8% in the TP arm, 47.7% in the GP arm and 42.9% in the DP arm (P > 0.05). The response rate of patients with radiochemotherapy was 69.9%, and 40.8% for those with chemotherapy alone (P < 0.05). In group NP, TP, GP and DP, median TTP was 5.7, 5.3, 5.9 and 5.5 months (P > 0.05) respectively, MST was 10.4, 10.6, 11.5 and 10.4 months (P > 0.05) respectively, 1-year survival rate was 41.9%, 41.1%, 43.1% and 42.9% (P > 0.05) respectively, and 2-year survival rate was 21.3%, 19.4%, 23.1% and 23.2% (P > 0.05) respectively.</p><p><b>CONCLUSIONS</b>The third-generation cisplatin-based chemotherapy regimens may be the standard treatment for advanced NSCLC, and their combination with radiotherapy may improve the therapeutic efficacy and prolong the survival of patients.</p>

3.
Journal of Medical Research ; (12)2006.
Article in Chinese | WPRIM | ID: wpr-565973

ABSTRACT

Objective To observe Mongolian gerbil's reproducing performance and growth indexes of biology for guidance of development and use of laboratory anima1. Methods 200 gerbils produced by seed-parents with good reproductive capacity and body constitution were selected (females and males were 100 each).When 2.5~3.0 months old,one male and one female were cohabited randomly for a long period of time.Results Every embryo gave birth to 14 young gerbils at best and 1 gerbil at least.The total embryos was 455 and the total young gerbils was 3191. The average young gerbils of every embryo were 7.01,and every embryo gave mostly birth to 5~9 young gerbils,accounting for 79.34 percent of all the embryos. The shortest time between two embryos was 20 days and the longest time was 127 days,and mostly were 20~60 days,accounting for 72.16 percent of total. Conclusion The body weight,body length and tail length of Mongolian gerbils grow rapidly from birth to 4 months old. The differences between female and male was not significantly before delectation,and the in the growing time after delectation,the body weight,body length and tail length of male gerbils were all greater than those of female gerbils.

4.
Journal of Medical Research ; (12)2006.
Article in Chinese | WPRIM | ID: wpr-565787

ABSTRACT

Objective To study the changes of antioxidant on ZCLA Mongolian gerbils' sera within different growth period.Methods The gerbils at the age of 1 month,3 months and 24 months were used in the experiment,with each 16(half male and half female),and the sera were collected for determining the MDA,SOD and GSH-Px.Results At the age of 3 months,MDA was the lowest,but GSH-Px was the highest,while the SOD was ascending with growing.Conclusion The changes of GSH-Px showed the direct relation to MDA,while the changes of the SOD was irrespective to the changes of MDA.

5.
Journal of Medical Research ; (12)2006.
Article in Chinese | WPRIM | ID: wpr-565384

ABSTRACT

Objective To observe the toxic reaction caused by short time contact with some common disinfectants such as 0.2% sodium hypochlorite,2%acetic acid and 2% glutaraldehyde and0.2%acetic acid,through wounded skin of laboratory animals and laborers.Methods Toxicity experiments of these disinfectants by artificial skin wound were carried on in guinea pigs,and the poisoning performance and the death situation of guinea pigs were observed.Results Light edema was caused by using 2% acetic acid,and the symptom disappeared after 3 days;it appeared the symptom of red bump and hemorrhagic spots after use 2% glutaraldehyde,and ecdysis occured after 4days,the red bump disappeared after 5 days with a brownish discoloration left;it didn't appear any toxic reaction by using 0.2% sodium hypochlorite and 0.2%acetic acid.Conclusion There was toxic effect of 2% acetic acid and 2% glutaraldehyde to animals and laborers.

6.
Chinese Journal of Lung Cancer ; (12): 240-242, 2004.
Article in Chinese | WPRIM | ID: wpr-345806

ABSTRACT

<p><b>BACKGROUND</b>To observe and compare the efficacy and safety of IEP and EP regimens for small cell lung cancer (SCLC).</p><p><b>METHODS</b>Sixty-four patients with SCLC pathologically proved were randomly divided into IEP group ( n =32) and EP group ( n =32).</p><p><b>RESULTS</b>All the 64 patients were evaluable for response and toxicity. In IEP group, the total responsive rate, responsive rates of limited-stage patients and extensive-stage patients were 84.4%(27/32), 100.0%(15/15) and 70.6%(12/17) respectively; while in EP group, those were 75.0%(24/32), 85.7%(12/14) and 66.7% (12/18) respectively. The median duration of remission was 6 months and 1-year survival rate was 62.5% in IEP group, and 5 months and 56.2% in EP group. There was no significant difference in response rate, median duration of remission and 1-year survival between the two groups ( P > 0.05). The main toxicity was myelosuppression. Incidences of leukopenia at grade III-IV, nausea, vomiting and alopecia were significantly higher in the IEP arm than those in the EP arm ( P < 0.01 ).</p><p><b>CONCLUSIONS</b>High response rates and tolerable toxicities are attainable for small cell lung cancer treated with IEP and EP. IEP regimen shows a similar response rate compared with EP regimen. They might be considered as relevant regimens in initial patients with small cell lung cancer.</p>

SELECTION OF CITATIONS
SEARCH DETAIL